Anti-CD41 mouse monoclonal unconjugated

Hansabiomed Life Sciences, founded in 2007 in Tallinn, Estonia is the pioneering company to be dedicated on the research and product development in the exosomes, Extracellular Vesicles and nanoparticles area.

Today HansaBioMed collaborates with various international research groups, both Academic and Industrial, and participates in the research projects aimed to implement the knowledge on the full potential of the EVs. With the expertise, gathered in over 15 years of activity, the company actively work not only to improve the current technologies for EV isolation and characterization but also to investigate new fields of application of the extracellular vesicles.
Together with the research activities, Hansabiomed provides its customers with high quality of services and products dedicated to the exosomes and EV research.

The catalogue of products includes a broad range of purified EVs, both human and cell derived, various tools for EV purification, enrichment and characterization.